Product Information
CLOBETASOL 0.05% OINTMENT is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1665 per GM under NDC 70710140104. Its NADAC has been published 304 times since May 8, 2019.
FDA first approved this application on Oct 27, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710140104
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
2/19/2025
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA210199FDA Approved
10/27/2017
TE Code
AB
On Market Since
3/22/2018
Pharmacological Classes
Price Statistics
The NADAC for CLOBETASOL 0.05% OINTMENT has been published 304 times since May 8, 2019, and over the history we have for it it has declined 76.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1665 per GM |
|---|---|
| All-time high | $0.7163 (May 15, 2019) |
| All-time low | $0.0961 (Nov 20, 2024) |
| Median price | $0.3176 |
| Average price | $0.3375 |
| Largest weekly change | +61.0% (Apr 21, 2021) |
| Weeks tracked | 304 |
| Tracking since | May 8, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-10.9%
5Y
-60.5%
All
-76.7%
Last surveyed Feb 26, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CLOBETASOL PROPIONATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBETASOL 0.05% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL 0.05% OINTMENT, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1665 per GM (NDC 70710140104), effective Feb 26, 2025.
How has the price of CLOBETASOL 0.05% OINTMENT changed over time?
Over the history we have for it, the NADAC for CLOBETASOL 0.05% OINTMENT has declined 76.7%. It has been tracked across 304 weekly CMS publications since May 8, 2019.
What are the highest and lowest recorded NADAC prices for CLOBETASOL 0.05% OINTMENT?
Since May 8, 2019, the NADAC for CLOBETASOL 0.05% OINTMENT has ranged from a low of $0.0961 (Nov 20, 2024) to a high of $0.7163 (May 15, 2019), with a median of $0.3176 per GM.
Are there cheaper alternatives to CLOBETASOL 0.05% OINTMENT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBETASOL 0.05% OINTMENT, is $0.1083 per GM — about 35% below CLOBETASOL 0.05% OINTMENT.
Who manufactures CLOBETASOL 0.05% OINTMENT?
CLOBETASOL 0.05% OINTMENT (NDC 70710140104) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.